Associated Papers
Similar Molecular Features in Two Cases of CARD14-Associated Papulosquamous Eruption.
Wang Y et al.
The Australasian Journal of Dermatology, 2025
Case report: Successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel CARD14 mutation.
Niedźwiedź M et al.
Frontiers in Medicine, 2024
Classification of domains in predicted structures of the human proteome.
Schaeffer RD et al.
Proceedings of the National Academy of Sciences of the United States of America, 2023
CARD14 Missense Variant Underlying CARD14-Associated Papulosquamous Eruption with Beneficial Response to Secukinumab.
Dai S et al.
Jid Innovations : Skin Science From Molecules to Population Health, 2023
Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
Klein B et al.
The British Journal of Dermatology, 2022
Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis.
Suleman S et al.
International Journal of Molecular Sciences, 2022
CARD14-mutations in pityriasis rubra pilaris and therapeutic response to ustekinumab - a hypothesis.
Volc-Platzer B
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg, 2020
Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.
Mellett M
Cellular Immunology, 2020
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
Craiglow BG et al.
Journal of the American Academy of Dermatology, 2018
CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T et al.
Frontiers in Immunology, 2018
Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.
Israel L et al.
Frontiers in Immunology, 2018
CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E et al.
The Journal of Investigative Dermatology, 2017
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.
Martorana D et al.
Frontiers in Immunology, 2017
CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.
Inoue N et al.
The Journal of Dermatology, 2016
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM et al.
The Journal of Investigative Dermatology, 2015
Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κB.
Li Q et al.
The Journal of Investigative Dermatology, 2015
Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: a case series.
Hong JB et al.
Acta Dermato-venereologica, 2014
The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders.
Scudiero I et al.
Journal of Cellular Physiology, 2014
CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort.
Sugiura K et al.
The Journal of Investigative Dermatology, 2014
The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
Journal of Dermatological Science, 2014
Familial pityriasis rubra pilaris is caused by mutations in CARD14.
Fuchs-Telem D et al.
American Journal of Human Genetics, 2012